Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001193125-21-043215
Filing Date
2021-02-16
Accepted
2021-02-16 06:26:56
Documents
2
Group Members
CORRIENTE MASTER FUND II, LPMARK L. HART III

Document Format Files

Seq Description Document Type Size
1 SC 13G/A d100462dsc13ga.htm SC 13G/A 73311
2 EX-99.A d100462dex99a.htm EX-99.A 3395
  Complete submission text file 0001193125-21-043215.txt   78286
Mailing Address 1401 FOCH ST SUITE 100 FORT WORTH TX 76107
Business Address 1401 FOCH ST SUITE 100 FORT WORTH TX 76107 8178700400
Corriente Advisors, LLC (Filed by) CIK: 0001406718 (see all company filings)

EIN.: 752939516 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address 100 HIGH STREET 28TH FLOOR BOSTON MA 02110
Business Address 100 HIGH STREET 28TH FLOOR BOSTON MA 02110 617-349-1971
CATABASIS PHARMACEUTICALS INC (Subject) CIK: 0001454789 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-88910 | Film No.: 21632099
SIC: 2834 Pharmaceutical Preparations